Marine Polysaccharides Carrageenans Enhance Eryptosis and Alter Lipid Order of Cell Membranes in Erythrocytes.

Anatolii Onishchenko, Yurii Kot, Liliya Tryfonyuk, Pavel Maksimchuk, Anton Tkachenko, Volodymyr Prokopiuk, Yevgen Posokhov, Tetyana Gorbach, Kateryna Kot, Oksana Nakonechna

Journal: Cell biochemistry and biophysics 2024;82(2):747-766

PMID: 38334853

Abstract

UNLABELLED

Aim In the current study, hemocompatibility of three major commercially available types of carrageenans (ι, κ and λ) was investigated focusing on eryptosis.

MATERIALS AND METHODS

Carrageenans of ι-, κ- and λ-types were incubated with washed erythrocytes (hematocrit 0.4%) at 0-1-5-10 g/L for either 24 h or 48 h. Incubation was followed by flow cytometry-based quantitative analysis of eryptosis parameters, including cell volume, cell membrane scrambling and reactive oxygen species (ROS) production, lipid peroxidation markers and confocal microscopy-based evaluation of intracellular Ca levels, assessment of lipid order in cell membranes and the glutathione antioxidant system. Confocal microscopy was used to assess carrageenan cellular internalization using rhodamine B isothiocyanate-conjugated carrageenans.

RESULTS

All three types of carrageenans were found to trigger eryptosis. Pro-eryptotic properties were type-dependent and λ-carrageenan had the strongest impact inducing phosphatidylserine membrane asymmetry, changes in cell volume, Ca signaling and oxidative stress characterized by ROS overproduction, activation of lipid peroxidation and severe glutathione system depletion. Eryptosis induction by carrageenans does not require their uptake by erythrocytes. Changes in physicochemical properties of cell membrane were also type-dependent. No carrageenan-induced generation of superoxide and hydroxyl radicals was observed in cell-free milieu.

CONCLUSIONS

Our findings suggest that ι-, κ- and λ-types trigger eryptosis in a type-dependent manner and indicate that carrageenans can be further investigated as potential eryptosis-regulating therapeutic agents.

© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Address: Research Institute of Experimental and Clinical Medicine, Kharkiv National Medical University, 4 Nauky ave, 61022, Kharkiv, Ukraine.; Department of Cryobiochemistry, Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkiv, 61015, Ukraine.; Research Institute of Experimental and Clinical Medicine, Kharkiv National Medical University, 4 Nauky ave, 61022, Kharkiv, Ukraine.; Institute of Health, National University of Water and Environmental Engineering, 11 Soborna st, 33000, Rivne, Ukraine.; Research Institute of Experimental and Clinical Medicine, Kharkiv National Medical University, 4 Nauky ave, 61022, Kharkiv, Ukraine.; Department of Organic Chemistry, Biochemistry, Paints and Coatings, The National Technical University "Kharkiv Polytechnic Institute", 2 Kyrpychova st, 61000, Kharkiv, Ukraine.; Department of Biochemistry, Kharkiv National Medical University, 4 Nauky ave., 61022, Kharkiv, Ukraine.; Department of Biochemistry, V. N. Karazin Kharkiv National University, 4 Svobody sq., 61022, Kharkiv, Ukraine.; Institute for Scintillation Materials, National Academy of Sciences of Ukraine, 60 Nauky ave, 61072, Kharkiv, Ukraine.; Research Institute of Experimental and Clinical Medicine, Kharkiv National Medical University, 4 Nauky ave, 61022, Kharkiv, Ukraine. [email protected].

Link outs

Free resources

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.